These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6260094

  • 1. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
    Motulsky HJ, Shattil SJ, Insel PA.
    Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1562-70. PubMed ID: 6260094
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Solubilization of human platelet alpha-adrenergic receptors: evidence for agonist-promoted receptor-effector association.
    Limbird LE, MacMillan ST, Smith SK.
    Adv Cyclic Nucleotide Res; 1981 Dec 31; 14():189-98. PubMed ID: 6116384
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ, Insel PA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2591-7. PubMed ID: 6291538
    [Abstract] [Full Text] [Related]

  • 7. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES, Addonizio VP, Shattil SJ.
    Am J Physiol; 1982 Jan 15; 242(1):H19-23. PubMed ID: 6277203
    [Abstract] [Full Text] [Related]

  • 8. Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets.
    Ferry N, Adnot S, Borsodi A, Lacombe ML, Guellaën G, Hanoune J.
    Biochem Biophys Res Commun; 1982 Sep 30; 108(2):708-14. PubMed ID: 6293500
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]-dihydroergocryptine.
    Boon NA, Elliott JM, Grahame-Smith DG, St John-Green T, Stump K.
    J Auton Pharmacol; 1983 Jun 30; 3(2):89-95. PubMed ID: 6309852
    [Abstract] [Full Text] [Related]

  • 10. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    Karliner JS, Motulsky HJ, Insel PA.
    Mol Pharmacol; 1982 Jan 30; 21(1):36-43. PubMed ID: 6127620
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA, Johnston CI.
    Mol Pharmacol; 1982 Nov 30; 22(3):589-94. PubMed ID: 6296653
    [Abstract] [Full Text] [Related]

  • 12. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE, Stump DC.
    Mol Pharmacol; 1982 Nov 30; 22(3):574-9. PubMed ID: 6296652
    [Abstract] [Full Text] [Related]

  • 13. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs.
    García-Sevilla JA, Hollingsworth PJ, Smnith CB.
    Eur J Pharmacol; 1981 Sep 24; 74(4):329-41. PubMed ID: 6271559
    [Abstract] [Full Text] [Related]

  • 14. GTP regulates binding of agonists to alpha 2-adrenergic receptors in human platelets.
    Brodde OE, Hardung A, Ebel H, Bock KD.
    Arch Int Pharmacodyn Ther; 1982 Aug 24; 258(2):193-207. PubMed ID: 6127987
    [Abstract] [Full Text] [Related]

  • 15. Increased central alpha-2 adrenergic receptors measured with [3H] yohimbine in the presence of sodium ion and guanylnucleotides.
    Woodcock EA, Murley B.
    Biochem Biophys Res Commun; 1982 Mar 15; 105(1):252-8. PubMed ID: 6284145
    [No Abstract] [Full Text] [Related]

  • 16. Evidence for high and low affinity alpha 2-receptors. Comparison of [3H]norepinephrine and [3H]phentolamine binding to human platelet membranes.
    Lynch CJ, Steer ML.
    J Biol Chem; 1981 Apr 10; 256(7):3298-303. PubMed ID: 6259160
    [No Abstract] [Full Text] [Related]

  • 17. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB, Michel T, Brenneman TB, Lefkowitz RJ.
    Endocrinology; 1982 Mar 10; 110(3):926-32. PubMed ID: 6120077
    [Abstract] [Full Text] [Related]

  • 18. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    Mooney JJ, Horne WC, Handin RI, Schildkraut JJ, Alexander RW.
    Mol Pharmacol; 1982 May 10; 21(3):600-8. PubMed ID: 6287197
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.